巨细胞动脉炎临床表现的遗传生物标志物界定不同患者亚组
该研究分析3498例巨细胞动脉炎(GCA)患者和15550名对照的全基因组基因型数据,识别与GCA临床表现相关的遗传风险因素。研究鉴定出7个HLA变异和7个非HLA关联,涉及6种临床表现,并通过潜在类别分析将GCA临床易感性分为4类,其中缺血/闭塞型为严重缺血和眼部并发症的高危亚组。
要点
- 7个HLA变异与不同GCA临床特征特异性相关,7个非HLA关联涉及6种临床表现。
- IL17A与肢体跛行、IL22RA1与下颌跛行相关,均涉及Th17通路;ATP2A2与颅外型相关。
- 潜在类别分析将GCA分为颅部为主型、混合型、颅外型和缺血/闭塞型4类,后者为高危亚组。
核心结论
- 本研究首次按GCA特异性临床表现分层的全基因组关联研究,加深了对GCA临床异质性遗传基础的理解。
- HLA和非HLA贡献因素与特定疾病表型相关,支持遗传分型指导GCA早期诊断和个体化管理的潜力。
研究设计与样本
- 研究分析3498例GCA患者和15550名对照的全基因组基因型数据,采用逻辑回归比较有或无各临床表现的患者以及各亚组患者与对照。
- 基于FUMA GWAS进行基因注释,并应用潜在类别分析评估相关变异对GCA患者进行遗传亚组分类的能力。
主要发现
- 鉴定出7个HLA变异与不同临床特征特异性相关,以及6种临床表现中的7个非HLA关联。
- 基因优先级分析提示IL17A(肢体跛行)和IL22RA1(下颌跛行)涉及Th17通路,ATP2A2(颅外型)编码促进主动脉瘤的转运体。
- 潜在类别分析将GCA临床易感性分为4类:颅部为主型、混合型、颅外型和缺血/闭塞型,后者代表严重缺血和眼部并发症的高危亚组。
关键数值与推荐
- 7个HLA变异与不同GCA临床特征特异性相关。
- 7个非HLA关联涉及6种临床表现。
- 潜在类别分析将GCA临床易感性分为4类:颅部为主型、混合型、颅外型和缺血/闭塞型。
临床怎么用
- 遗传分型可能有助于GCA的早期诊断和个体化管理,尤其识别缺血/闭塞型高危亚组以预防严重缺血和眼部并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Giant cell arteritis (GCA) is a clinically heterogeneous disease, which complicates both diagnosis and management. This study aimed to identify genetic risk factors associated with GCA clinical manifestations and evaluate their utility for defining clinical phenotypes. METHODS: Genome-wide genotype data from 3498 patients with GCA and 15,550 controls were analysed to investigate the genetic architecture of GCA manifestations. Logistic regression was used to compare patients with and without each manifestation, as well as each subgroup of patients vs controls. Gene annotation was conducted based on functional information using Functional Mapping and Annotation of Genome-Wide Association Studies (FUMA GWAS). Latent class analysis (LCA) was applied to evaluate the ability of associated variants to classify patients with GCA into genetic subgroups. RESULTS: We identified 7 human leukocyte antigen (HLA) variants specifically associated with different clinical features. Furthermore, 7 non-HLA associations across 6 clinical manifestations were found. Gene prioritisation highlighted biologically relevant candidate genes for GCA pathogenesis, including IL17A (limb claudication) and IL22RA1 (jaw claudication), both involved in the Th17 pathway, and ATP2A2 (extracranial form), encoding a transporter that promotes aortic aneurysms. Notably, LCA grouped GCA clinical predisposition into 4 classes capturing cranial-predominant, mixed, extracranial, and ischaemic/occlusive patterns, the latter representing a high-risk subgroup for severe ischaemic and ocular complications. CONCLUSIONS: This first genome-wide association study stratified by GCA-specific manifestations deepens our understanding of the genetic basis underlying GCA clinical heterogeneity. Our findings highlight HLA and non-HLA contributors to specific disease phenotypes and support the potential of genetic profiling to guide early diagnosis and personalised management in GCA.
引用
- Borrego-Yaniz G, Fuentes-Moreno V, Ortiz-Fernández L, et al. Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups. Ann Rheum Dis. 2026. PMID: 42399125. doi:10.1016/j.ard.2026.06.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。